Skip to content

LAS-R Human CRP Test K771535

by Hyland Therapeutic Div., Travenol Laboratories 510(k)

Active United States

510(k) K771535

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK771535 Date2 Sep 1977ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

Full name
Las-R Human Crp Test
510(k) Number
FDA Product Code
DCN
Device Class
Class II
Regulation
21 CFR Part 866.5270
Advisory Committee
Immunology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 6 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The LAS-R Human CRP Test is a system for detecting C-Reactive Protein. It is classified as a Class 2 device within immunology.

This device was authorized by the FDA through a 510(k) clearance (K771535) on September 2, 1977, after being deemed substantially equivalent. It was manufactured by Hyland Therapeutic Div., Travenol Laboratories.

Other devices from Hyland Therapeutic Div., Travenol Laboratories

See all devices from Hyland Therapeutic Div., Travenol Laboratories →

Questions

AI-generated answers, 6 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the LAS-R Human CRP Test used for?

    The LAS-R Human CRP Test is designed to detect C-Reactive Protein in human samples. It is classified as a Class 2 device within the field of immunology.

  • Who manufactured the LAS-R Human CRP Test?

    The LAS-R Human CRP Test was manufactured by Hyland Therapeutic Div., Travenol Laboratories.

  • What is the regulatory status of the LAS-R Human CRP Test?

    The LAS-R Human CRP Test was cleared by the FDA through a 510(k) submission (K771535) on September 2, 1977, after being deemed substantially equivalent.